These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28234447)

  • 1. Chemical Strategies To Target Bacterial Virulence.
    Garland M; Loscher S; Bogyo M
    Chem Rev; 2017 Mar; 117(5):4422-4461. PubMed ID: 28234447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
    Dickey SW; Cheung GYC; Otto M
    Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Roles of Toxin-Antitoxin Modules in Bacterial Pathogenesis.
    Kędzierska B; Hayes F
    Molecules; 2016 Jun; 21(6):. PubMed ID: 27322231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxin-Antitoxin Systems and their Role in Maintaining the Pathogenic Potential of Causative Agents of Sapronoses.
    Andryukov BG; Somova LM; Timchenko NF; Bynina MP; Lyapun IN
    Infect Disord Drug Targets; 2020; 20(5):570-584. PubMed ID: 31322076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies for combating multidrug-resistant bacteria.
    Wright GD; Sutherland AD
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.
    Guillard T; Pons S; Roux D; Pier GB; Skurnik D
    Bioessays; 2016 Jul; 38(7):682-93. PubMed ID: 27248008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The search for novel antibiotics--strategies and current approaches].
    Schmid P
    Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):498-512. PubMed ID: 25872259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial adhesion--a source of alternate antibiotic targets.
    Cusumano CK; Hultgren SJ
    IDrugs; 2009 Nov; 12(11):699-705. PubMed ID: 19844856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-virulence strategies to combat bacteria-mediated disease.
    Rasko DA; Sperandio V
    Nat Rev Drug Discov; 2010 Feb; 9(2):117-28. PubMed ID: 20081869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
    Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
    Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding the antibacterial properties of flavonoids.
    Cushnie TP; Lamb AJ
    Int J Antimicrob Agents; 2011 Aug; 38(2):99-107. PubMed ID: 21514796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.
    Ogawara H
    J Antibiot (Tokyo); 2021 Jan; 74(1):24-41. PubMed ID: 32647212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections.
    Russo TA; Spellberg B; Johnson JR
    J Infect Dis; 2016 Mar; 213(6):901-3. PubMed ID: 26563238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era.
    Neville N; Jia Z
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disarming pathogens: benefits and challenges of antimicrobials that target bacterial virulence instead of growth and viability.
    Totsika M
    Future Med Chem; 2017 Mar; 9(3):267-269. PubMed ID: 28207349
    [No Abstract]   [Full Text] [Related]  

  • 17. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance in ocular bacterial pathogens.
    Sharma S
    Indian J Med Microbiol; 2011; 29(3):218-22. PubMed ID: 21860100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human health aspects of antibiotic use in food animals: a review].
    van den Bogaard AE
    Tijdschr Diergeneeskd; 2001 Sep; 126(18):590-5. PubMed ID: 11596533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type III bacterial secretion system, a promising target for the development of a new generation of antibiotic drugs].
    Gintsburg AL; Zigangirova NA; Zorina VV
    Vestn Ross Akad Med Nauk; 2008; (10):34-9. PubMed ID: 19140396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.